FdaApplication
ANDA 208813
Identifiers
- fda_app_no: ANDA208813
Properties
| Property | Value |
|---|---|
| applicant_name | RISING PHARMA HOLDINGS INC |
| application_type | ANDA |
| approval_date | 2018-12-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TOREMIFENE CITRATE | TOREMIFENE CITRATE | EQ 60MG BASE | TABLET;ORAL |
1 product